• SENSEX 76,828.92
    -88.93 (--0.12%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • SBI Life Insuran
    1,704.10 2,132.90(%)
  • Global Health
    1,422.10 1,542.00(%)
  • SFC Enviro.
    478.20 424.85(%)
  • BLS Polymers
    288.00 285.25(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • Jio Platforms
    1,424.65 1,356.40(%)
  • Reliance Industries
    1,296.20 1,152.30(%)
  • ITC
    283.50 421.70(%)
  • Godrej Consumer
    851.20 1,275.00(%)
  • Nippon Life Ind.
    1,001.75 1,269.00(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • SBI
    987.75 1,234.80(%)
  • Fractal Analyt.
    834.60 1,119.60(%)
  • Welspun Corp
    2,360.00 2,899.95(%)
  • Welspun Living
    267.40 257.00(%)
  • KRN Heat Exchan
    982.95 589.75(%)
  • Saregama India
    579.80 574.85(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

JFL Life Sciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 76743.0
  • ISIN : INE0LA901015
10.75 1 (4.88%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    10.75

  • Today’s High

    10.75

  • Open

    10.75

  • Perv Close

    10.25

  • 52W Low

    8.55

  • 52W High

    14.70

Key Indicators

  • P/E(TTM)

    3.94

  • Mar.Cap (₹Cr.)

    35.47

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.52

  • Debt-Equity Ratio

    4.88

  • AGM Date

    03-Nov-2026

  • EPS

    2.73

  • P/E Ratio

    3.94

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    35.47

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    33.00

  • BV (₹)

    15.50

  • Sales( ₹ in Cr.)

    131.38

  • NP (in Cr.)

    6.40

  • NP Var(%)

    54.0

  • Div%

    0.0

  • CPS (₹)

    2.30

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    35.47

  • 52 Week High

    14.70

  • 52 Week Low

    8.55

  • Price BSE

    0.0

  • Price NSE

    11.00

  • Market Capital( in Cr.)

    35.47

  • P/C Ratio

    4.90

  • P/E Ratio

    5.70

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 131.38 82.04 46.55 42.83 33.59 32.77
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 131.38 82.04 46.55 42.83 33.59 32.77
Other Income 0.07 0.01 0.52 1.64 0.89 0.09
Stock Adjustments 0.08 0.66 -0.62 -2.45 4.69 -0.15
Total Income 131.53 82.71 46.45 42.02 39.17 32.71
EXPENDITURE :            
Raw Materials 115.06 66.77 38.23 33.26 30.49 28.76
Power and Fuel Cost 0.37 0.43 0.48 0.34 0.30 0.19
Employee Cost 1.12 1.01 2.01 1.83 1.43 0.98
Other Manufacturing Expenses 1.49 0.22 0.15 0.29 0.08 0.02
Selling and Administration Expenses 1.57 6.00 0.46 0.63 0.56 0.29
Miscellaneous Expenses 0.14 0.07 0.05 0.10 0.06 0.22
Employee Benefit Expenses 1.12 1.01 2.01 1.83 1.43 0.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 119.75 74.50 41.38 36.45 32.92 30.46
Operating Profit 11.78 8.21 5.07 5.56 6.25 2.25
Interest 2.11 1.08 0.83 1.42 2.08 1.23
Gross Profit 9.67 7.13 4.24 4.14 4.17 1.02
Depreciation 1.08 0.99 0.44 0.43 0.37 0.28
Profit Before Tax 8.59 6.14 3.80 3.71 3.80 0.74
Current Tax 2.16 1.53 0.80 0.91 0.95 0.16
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.04 0.45 -0.30 0.00 0.04 0.04
Reported Net Profit 6.40 4.16 3.31 2.81 2.81 0.54
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 6.40 4.16 3.31 2.81 2.81 0.54
Adjustment below Net Profit 0.01 -6.35 0.00 0.00 -1.86 0.00
P & L Balance brought forward 6.46 8.93 5.62 2.81 1.86 1.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.28 0.00 0.00 0.00 0.00
P & L Balance carried down 12.87 6.46 8.93 5.62 2.81 1.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 2.50 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.25 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.94 1.26 3.01 2.55 3.50 10.91
Earnings Per Share(Adj)-Unit Curr 1.94 1.20 0.96 0.81 - -
Book Value 13.90 11.96 32.35 29.34 14.08 138.28
Book Value(Adj)-Unit Curr 13.90 11.42 10.29 9.34 - -

Shareholding Pattern

  • Promoter Group

    67.47%

  • Public Share Holding

    32.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 22,261,323 67.47 22,261,323 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 22,261,323 67.47 22,261,323 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 416,000 1.26 416,000 11
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 202,000 0.61 202,000 15
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 776,000 2.35 776,000 54
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,453,000 10.47 3,453,000 63
Individuals holding nominal share capital up to Rs. 1 lakh 5,887,000 17.84 5,887,000 789
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,734,000 32.53 10,734,000 932
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 32,995,323 100.00 32,995,323 943

Company Background

JFL Life Sciences LtdPharmaceuticals - Indian - Formulations

  • JFL Life Sciences Ltd
  • BSE Code : 76743.0
  • ISIN : INE0LA901015

  • Incorporation Year

    2010

  • Registered Office

    309 Satyam Mall Opp Saman Comp
    Nr.Vishweshwar Mahadev Mandir, Ahmedabad,
    Gujarat-380015

  • Telephone

    91-93772 95575

  • FAX

  • Chairman

    Smiral Ashwinkumar Patel

  • Managing Director

    Smiral Ashwinkumar Patel

  • Company Secretary

    Hiral Chudasama

  • Auditor

    Doshi Doshi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

JFL Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
JFL Life 10.75 131.45 131.38 3.94 18.16
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77